Scinai Immunotherapeutics Ltd (SCNI) earnings · rev $1.3M
These earnings events as JSON? API free 100/dayScinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
This SCNI earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M.
When the next SCNI 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 99.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SCNI research stays on the stock page; the tape stays on the quote page.
SCNI earnings FAQ
What are SCNI's latest revenue and net income?
Latest cached Scinai Immunotherapeutics Ltd (SCNI) revenue for Dec 31, 2025 was $1.3M. Net income was -$8.3M. Statements: https://lician.com/financials/scni
What period does the latest SCNI earnings print cover?
The latest cached Scinai Immunotherapeutics Ltd (SCNI) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did SCNI revenue change from the prior cached period?
Cached Scinai Immunotherapeutics Ltd (SCNI) revenue was up 99.2% from $658.0K (Dec 31, 2024) to $1.3M (Dec 31, 2025). Statements: https://lician.com/financials/scni
Where are SCNI earnings listed?
Cached earnings facts for Scinai Immunotherapeutics Ltd (SCNI) are listed at https://lician.com/earnings/scni. Statements: https://lician.com/financials/scni
Not investment advice.